Exact Mass: 479.2189
Exact Mass Matches: 479.2189
Found 500 metabolites which its exact mass value is equals to given mass value 479.2189
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicardipine
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3803 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3810 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7839; ORIGINAL_PRECURSOR_SCAN_NO 7837 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7818; ORIGINAL_PRECURSOR_SCAN_NO 7816 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7789; ORIGINAL_PRECURSOR_SCAN_NO 7787 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3822; ORIGINAL_PRECURSOR_SCAN_NO 3819 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3811 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3884; ORIGINAL_PRECURSOR_SCAN_NO 3883 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7827; ORIGINAL_PRECURSOR_SCAN_NO 7825 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7806; ORIGINAL_PRECURSOR_SCAN_NO 7805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7845; ORIGINAL_PRECURSOR_SCAN_NO 7843 C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
N-[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline 3-nitrooxypropyl ester
Proxazole citrate
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Phe Ala Asp Lys
nicardipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Asp Phe Lys
Ala Asp Phe Gln
Ala Asp Lys Phe
Ala Asp Gln Phe
Ala Glu Phe Asn
Ala Glu Asn Phe
Ala Phe Asp Lys
Ala Phe Asp Gln
Ala Phe Glu Asn
Ala Phe Gly Trp
Ala Phe Lys Asp
Ala Phe Asn Glu
Ala Phe Gln Asp
Ala Phe Trp Gly
Ala Gly Phe Trp
Ala Gly Trp Phe
Ala Ile Asn Tyr
Ala Ile Tyr Asn
Ala Lys Asp Phe
Ala Lys Phe Asp
Ala Lys Met Met
Ala Leu Asn Tyr
Ala Leu Tyr Asn
Ala Met Lys Met
Ala Met Met Lys
Ala Asn Glu Phe
Ala Asn Phe Glu
Ala Asn Ile Tyr
Ala Asn Leu Tyr
Ala Asn Tyr Ile
Ala Asn Tyr Leu
Ala Gln Asp Phe
Ala Gln Phe Asp
Ala Gln Val Tyr
Ala Gln Tyr Val
Ala Val Gln Tyr
Ala Val Tyr Gln
Ala Trp Phe Gly
Ala Trp Gly Phe
Ala Tyr Ile Asn
Ala Tyr Leu Asn
Ala Tyr Asn Ile
Ala Tyr Asn Leu
Ala Tyr Gln Val
Ala Tyr Val Gln
Cys Glu Lys Thr
Cys Glu Thr Lys
Cys Lys Glu Thr
Cys Lys Met Val
Cys Lys Thr Glu
Cys Lys Val Met
Cys Met Lys Val
Cys Met Val Lys
Cys Arg Thr Thr
Cys Thr Glu Lys
Cys Thr Lys Glu
Cys Thr Arg Thr
Cys Thr Thr Arg
Cys Val Lys Met
Cys Val Met Lys
Asp Ala Phe Lys
Asp Ala Phe Gln
Asp Ala Gln Phe
Asp Phe Ala Gln
Asp Phe Gln Ala
Asp Lys Met Ser
Asp Lys Ser Met
Asp Met Lys Ser
Asp Met Ser Lys
Asp Gln Ala Phe
Asp Gln Phe Ala
Asp Ser Lys Met
Asp Ser Met Lys
Glu Ala Phe Asn
Glu Ala Asn Phe
Glu Cys Lys Thr
Glu Cys Thr Lys
Glu Phe Ala Asn
Glu Phe Gly Gln
Glu Phe Asn Ala
Glu Phe Gln Gly
Glu Gly Phe Gln
Glu Gly Gln Phe
Glu Lys Cys Thr
Glu Lys Thr Cys
Glu Asn Ala Phe
Glu Asn Phe Ala
Glu Gln Phe Gly
Glu Gln Gly Phe
Glu Thr Cys Lys
Glu Thr Lys Cys
Phe Ala Asp Gln
Phe Ala Glu Asn
Phe Ala Gly Trp
Phe Ala Asn Glu
Phe Ala Gln Asp
Phe Ala Trp Gly
Phe Asp Ala Gln
Phe Asp Gln Ala
Phe Glu Ala Asn
Phe Glu Gly Gln
Phe Glu Asn Ala
Phe Glu Gln Gly
Phe Gly Ala Trp
Phe Gly Glu Gln
Phe Gly Gln Glu
Phe Gly Trp Ala
Phe Asn Ala Glu
Phe Asn Glu Ala
Phe Gln Ala Asp
Phe Gln Asp Ala
Phe Gln Glu Gly
Phe Gln Gly Glu
Phe Trp Ala Gly
Phe Trp Gly Ala
Gly Ala Phe Trp
Gly Ala Trp Phe
Gly Glu Phe Gln
Gly Glu Gln Phe
Gly Phe Ala Trp
Gly Phe Glu Gln
Gly Phe Gln Glu
Gly Phe Trp Ala
Gly Gln Glu Phe
Gly Gln Phe Glu
Gly Trp Ala Phe
Gly Trp Phe Ala
Gly Tyr Leu Gln
Lys Ala Met Met
Lys Cys Glu Thr
Lys Cys Met Val
Lys Cys Thr Glu
Lys Cys Val Met
Lys Asp Met Ser
Lys Asp Ser Met
Lys Glu Cys Thr
Lys Glu Thr Cys
Lys Met Ala Met
Lys Met Cys Val
Lys Met Asp Ser
Lys Met Met Ala
Lys Met Ser Asp
Lys Met Val Cys
Lys Ser Asp Met
Lys Ser Met Asp
Lys Thr Cys Glu
Lys Thr Glu Cys
Lys Val Cys Met
Lys Val Met Cys
Met Ala Lys Met
Met Ala Met Lys
Met Cys Lys Val
Met Cys Val Lys
Met Asp Lys Ser
Met Asp Ser Lys
Met Lys Ala Met
Met Lys Cys Val
Met Lys Asp Ser
Met Lys Met Ala
Met Lys Ser Asp
Met Lys Val Cys
Met Met Ala Lys
Met Met Lys Ala
Met Gln Thr Thr
Met Arg Ser Ser
Met Ser Asp Lys
Met Ser Lys Asp
Met Ser Arg Ser
Met Ser Ser Arg
Met Thr Gln Thr
Met Thr Thr Gln
Met Val Cys Lys
Met Val Lys Cys
Asn Ala Glu Phe
Asn Ala Phe Glu
Asn Glu Ala Phe
Asn Glu Phe Ala
Asn Phe Ala Glu
Asn Phe Glu Ala
Asn Pro Ser Tyr
Asn Pro Tyr Ser
Asn Ser Pro Tyr
Asn Ser Tyr Pro
Asn Tyr Ala Ile
Asn Tyr Ala Leu
Asn Tyr Ile Ala
Asn Tyr Leu Ala
Asn Tyr Pro Ser
Asn Tyr Ser Pro
Pro Asn Ser Tyr
Pro Asn Tyr Ser
Pro Ser Asn Tyr
Pro Ser Tyr Asn
Pro Tyr Asn Ser
Pro Tyr Ser Asn
Gln Ala Asp Phe
Gln Ala Phe Asp
Gln Ala Val Tyr
Gln Ala Tyr Val
Gln Asp Ala Phe
Gln Asp Phe Ala
Gln Glu Phe Gly
Gln Glu Gly Phe
Gln Phe Ala Asp
Gln Phe Asp Ala
Gln Phe Glu Gly
Gln Phe Gly Glu
Gln Phe Ser Val
Gln Phe Val Ser
Gln Gly Glu Phe
Gln Gly Phe Glu
Gln Gly Ile Tyr
Gln Gly Leu Tyr
Gln Gly Tyr Ile
Gln Gly Tyr Leu
Gln Ile Gly Tyr
Gln Ile Tyr Gly
Gln Leu Gly Tyr
Gln Leu Tyr Gly
Gln Met Thr Thr
Gln Ser Phe Val
Gln Ser Val Phe
Gln Thr Met Thr
Gln Thr Thr Met
Gln Val Ala Tyr
Gln Val Phe Ser
Gln Val Ser Phe
Gln Tyr Gly Leu
Gln Tyr Ile Gly
Gln Tyr Leu Gly
Gln Tyr Val Ala
Arg Cys Thr Thr
Arg Met Ser Ser
Arg Ser Met Ser
Arg Ser Ser Met
Arg Thr Cys Thr
Arg Thr Thr Cys
Ser Asp Lys Met
Ser Asp Met Lys
Ser Phe Ile Asn
Ser Phe Leu Asn
Ser Phe Asn Ile
Ser Phe Asn Leu
Ser Phe Gln Val
Ser Phe Val Gln
Ser Ile Phe Asn
Ser Ile Asn Phe
Ser Lys Asp Met
Ser Lys Met Asp
Ser Leu Phe Asn
Ser Leu Asn Phe
Ser Met Asp Lys
Ser Met Lys Asp
Ser Met Arg Ser
Ser Met Ser Arg
Ser Asn Phe Ile
Ser Asn Phe Leu
Ser Asn Ile Phe
Ser Asn Leu Phe
Ser Asn Pro Tyr
Ser Asn Tyr Pro
Ser Pro Asn Tyr
Ser Pro Tyr Asn
Ser Gln Phe Val
Ser Gln Val Phe
Ser Arg Met Ser
Ser Arg Ser Met
Ser Ser Met Arg
Ser Ser Arg Met
Ser Ser Thr Trp
Ser Ser Trp Thr
Ser Thr Ser Trp
Ser Thr Trp Ser
Ser Val Phe Gln
Ser Val Gln Phe
Ser Trp Ser Thr
Ser Trp Thr Ser
Ser Tyr Asn Pro
Ser Tyr Pro Asn
Thr Cys Glu Lys
Thr Cys Lys Glu
Thr Cys Arg Thr
Thr Cys Thr Arg
Thr Glu Cys Lys
Thr Glu Lys Cys
Thr Phe Asn Val
Thr Phe Val Asn
Thr Lys Cys Glu
Thr Lys Glu Cys
Thr Met Gln Thr
Thr Met Thr Gln
Thr Asn Phe Val
Thr Asn Val Phe
Thr Gln Met Thr
Thr Gln Thr Met
Thr Arg Cys Thr
Thr Arg Thr Cys
Thr Ser Ser Trp
Thr Ser Trp Ser
Thr Thr Cys Arg
Thr Thr Met Gln
Thr Thr Gln Met
Thr Thr Arg Cys
Thr Val Phe Asn
Thr Val Asn Phe
Thr Trp Ser Ser
Val Ala Gln Tyr
Val Ala Tyr Gln
Val Cys Lys Met
Val Cys Met Lys
Val Phe Asn Thr
Val Phe Gln Ser
Val Phe Ser Gln
Val Phe Thr Asn
Val Lys Cys Met
Val Lys Met Cys
Val Met Cys Lys
Val Met Lys Cys
Val Asn Phe Thr
Val Asn Thr Phe
Val Gln Ala Tyr
Val Gln Phe Ser
Val Gln Ser Phe
Val Gln Tyr Ala
Val Ser Phe Gln
Val Ser Gln Phe
Val Thr Phe Asn
Val Thr Asn Phe
Val Tyr Ala Gln
Val Tyr Gln Ala
Trp Ala Phe Gly
Trp Ala Gly Phe
Trp Phe Ala Gly
Trp Phe Gly Ala
Trp Gly Ala Phe
Trp Gly Phe Ala
Trp Ser Ser Thr
Trp Ser Thr Ser
Trp Thr Ser Ser
Tyr Ala Ile Asn
Tyr Ala Leu Asn
Tyr Ala Asn Ile
Tyr Ala Asn Leu
Tyr Ala Gln Val
Tyr Ala Val Gln
Tyr Gly Ile Gln
Tyr Gly Leu Gln
Tyr Gly Gln Ile
Tyr Gly Gln Leu
Tyr Ile Ala Asn
Tyr Ile Gly Gln
Tyr Ile Asn Ala
Tyr Ile Gln Gly
Tyr Leu Ala Asn
Tyr Leu Gly Gln
Tyr Leu Asn Ala
Tyr Leu Gln Gly
Tyr Asn Ala Ile
Tyr Asn Ala Leu
Tyr Asn Ile Ala
Tyr Asn Leu Ala
Tyr Asn Pro Ser
Tyr Asn Ser Pro
Tyr Pro Asn Ser
Tyr Pro Ser Asn
Tyr Gln Ala Val
Tyr Gln Gly Ile
Tyr Gln Gly Leu
Tyr Gln Ile Gly
Tyr Gln Leu Gly
Tyr Gln Val Ala
Tyr Ser Asn Pro
Tyr Ser Pro Asn
Tyr Val Ala Gln
Tyr Val Gln Ala
PROPIONIC ACID (1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYLPROPYL ESTER
(1S,2R)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
2-[3-[(2,6-Dimethylphenoxy)methyl]-4-methoxyphenyl]-3-(3-pyridinylmethyl)-1,2-dihydroquinazolin-4-one
N,N-Diethyl-2-[4-[6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl]phenoxy]ethanamine hydrochloride
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
(2R)-2-amino-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylpropanoic acid
4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(1R,9S,10S,11S)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(1S,9R,10R,11R)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2R,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(2R,3R,3aS,9bS)-1-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-N-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(2R,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(2S,3S,3aR,9bR)-1-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-N-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N,N-dimethyl-3-[4-[(1R,5S)-6-[[2-(trifluoromethyl)phenyl]methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
3-O-[2-[benzyl(methyl)amino]ethyl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
1-Ethyl-4-(5-methylfuran-2-carbonyl)-1-(3-morpholin-4-ylpropyl)spiro[indole-3,5-pyrrolidine]-2,2,3-trione
2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester
(8S)-cystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid
A docosanoid that is (7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid in which a cysteinyl group is attached at position 8S via a sulfide linkage. An intermediate of specialised proresolving mediators.